US smokers who want to quit getting new option
A cheaper pill without known side-effects is on the way
Washington
RICK Stewart didn't know about the laburnum trees growing in Bulgaria - and their potential to produce a drug for quitting smoking - back when he was the chief executive of pharmaceutical company Amarin. He was too deep inside the drug industry, a place often criticised for its short- sighted focus on profits. He had to fail first. Only then could he spot the opportunity in those yellow-flowering trees.
Now, with the help of the US National Institutes of Health, he is trying to introduce the laburnum-derived drug to the American market.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Holiday Inn owner IHG’s Q1 revenue up 2.6%, leisure travel demand remains strong
WSJ moves Asia headquarters from Hong Kong to Singapore
South Korea to slap fines on food suppliers for ‘shrinkflation’
Olam outbids Dreyfus’ sweetened deal for Australia’s Namoi, raises offer to A$0.66 per share
Live Nation’s revenue beats estimates as boom in concerts drive ticket sales
Jim Beam owner bets on canned vodka cocktails to double revenue